Company Encyclopedia
View More
name
Alps
ALPS.US
Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia.
1.868 T
ALPS.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Alps closes business combination with Globalink Investment Inc., ordinary shares to list on Nasdaq as "ALPS" on Oct 31, 2025.

    On October 31, 2025, Alps common stocks are set to be listed on the Nasdaq exchange using the trading symbol "ALPS."

    Unusual Whales·
    US
    ALPS
    +36.28%
    Unusual Whales·
    US
    ALPS
    +36.28%

    Alps Announces Closing of Business Combination with Globalink Investment Inc.

    Alps ordinary shares to list on the Nasdaq under the symbol "ALPS" on October 31, 2025 Alps ordinary shares to list on the Nasdaq under the symbol "ALPS" on October ...

    GlobeNewswire·
    US
    ALPS
    +36.28%
    GlobeNewswire·
    US
    ALPS
    +36.28%

    Globalink Investment Inc. (NASDAQ:GLLI) Short Interest Up 300.0% in September

    Globalink Investment Inc. (NASDAQ:GLLI) experienced a 300% increase in short interest in September, rising from 500 shares to 2,000 shares by September 30th. The short-interest ratio is currently 0.7 days based on an average daily trading volume of 3,000 shares. The stock price remained stable at $15.00, with a market cap of $52.77 million and a P/E ratio of -65.21. The company focuses on mergers and acquisitions in the medical technology and green energy sectors.

    Market Beat·
    US
    GLLI
    0.00%
    US
    ALPS
    +36.28%
    Market Beat·
    US
    GLLI
    0.00%
    US
    ALPS
    +36.28%

    Globalink Investment Approves Merger with Alps Life Sciences

    Globalink Investment Inc. (GLLI) has received stockholder approval for a merger with Alps Life Sciences Inc. during a special meeting on October 7, 2025. This includes a Redomestication Merger and an Acquisition Merger, enhancing Globalink's market position. Stockholders also approved an amendment to remove the net tangible asset requirement, aiding the merger's completion. Globalink focuses on mergers and acquisitions in the investment industry, with a current market cap of $52.76M and an average trading volume of 2,447 shares.

    Tip Ranks·
    US
    GLLI
    0.00%
    US
    ALPS
    +36.28%
    Tip Ranks·
    US
    GLLI
    0.00%
    US
    ALPS
    +36.28%

    Globalink Investment Inc held special meeting of stockholders

    Globalink Investment Inc. held a special meeting of stockholders on October 7, 2025, where stockholders approved the merger with Alps Global Holding Pubco, which will remain the surviving publicly traded entity. An amendment to the Amended and Restated Certificate of Incorporation was also approved.

    Reuters·
    US
    GLLI
    0.00%
    US
    ALPS
    +36.28%
    Reuters·
    US
    GLLI
    0.00%
    US
    ALPS
    +36.28%